In this context, our previous study identified Colony Stimulating Factor 1 receptor (CSF1R) as a new therapeutic target, as its inhibition induced anti-inflammatory effects associated with a decrease in epileptic seizures in a pilocarpine mouse model of epilepsy [6]. The gene discussed is CSF1R; the disease is epilepsy.